Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check45 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check67 days agoChange DetectedThe website has updated the intervention details and contact information for Principal Investigator Dan Zhao, MD, reflecting a new version (v2.14.0) while removing the previous version's details.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.